A study published in Science Advances shares new insights into how two of the most common types of chimeric antigen receptor ...

A study published in Science Advances shares new insights into how two of the most common types of chimeric antigen receptor ...

A groundbreaking study from Baylor College of Medicine explores how two types of CAR T cells target cancer, shedding light on ...

The company has three clinical CAR-T programmes backed by its precision-targeting cellular system Imod platform technology.

The field of immunogenetics has made significant strides in understanding the adaptive immune response, which has evolved over 450 million years across a ...

Russell W. Jenkins, MD, PhD, a physician investigator in the Krantz Family Center for Cancer Research at the Mass General ...

Metastatic clear cell renal cell carcinoma (mccRCC), an aggressive type of kidney cancer, has historically presented limited treatment options. Immune checkpoint inhibitors, a form of immunotherapy, ...

A clinical-stage biotechnology company will advance a novel autologous chimeric antigen receptor T-cell therapy that targets ...

Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.

An Institute for Value-Based Medicine regional event in Houston, Texas, covered inconsistencies with the integration of precision medicine in oncology practices, the evolution of treatment for ...